Karyopharm Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Karyopharm Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2024.
  • Karyopharm Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 125K shares.
  • Karyopharm Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 114M shares, a 39.5% increase from 2022.
  • Karyopharm Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 81.9M shares, a 8.85% increase from 2021.
  • Karyopharm Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 75.2M shares, a 4.41% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 125K* +10.6K Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 121M +6.82M +5.97% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 115M +1.97M +1.74% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 114M +32.4M +39.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 114K* -80.1M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 114M +34.6M +43.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 113M +35.9M +46.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 81.9M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 80.2M +4.75M +6.29% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 79.7M +4.46M +5.93% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 77.6M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q3 2021 75.5M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 75.2M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.